|
OGFOD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.747560E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.781020E-01 |
| Normal-vs-Stage2 |
1.404620E-01 |
| Normal-vs-Stage3 |
3.486200E-01 |
| Normal-vs-Stage4 |
3.660000E-01 |
| Stage1-vs-Stage2 |
5.003800E-01 |
| Stage1-vs-Stage3 |
7.011800E-01 |
| Stage1-vs-Stage4 |
8.034200E-01 |
| Stage2-vs-Stage3 |
4.361800E-01 |
| Stage2-vs-Stage4 |
4.928600E-01 |
| Stage3-vs-Stage4 |
9.635800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.928230E-01 |
| Normal-vs-AfricanAmerican |
5.530000E-02 |
| Normal-vs-Asian |
5.795200E-01 |
| Caucasian-vs-AfricanAmerican |
2.897400E-01 |
| Caucasian-vs-Asian |
5.543200E-01 |
| AfricanAmerican-vs-Asian |
1.790010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.766000E-01 |
| Normal-vs-Female |
1.069250E-01 |
| Male-vs-Female |
6.500400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.245820E-01 |
| Normal-vs-Age(41-60Yrs) |
2.254600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.861400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.221000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.313800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.541000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.719200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.286200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.500000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.619800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.226200E-01 |
| Classical-VS-Follicular |
2.238200E-02 |
| Classical-VS-Other |
4.375800E-02 |
| Classical-VS-Normal |
2.459900E-02 |
| Tall-VS-Follicular |
2.978200E-01 |
| Tall-VS-Other |
1.769240E-01 |
| Tall-VS-Normal |
2.923200E-01 |
| Follicular-VS-Other |
3.395000E-01 |
| Follicular-VS-Normal |
9.164600E-01 |
| Other-VS-Normal |
2.716600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.146000E-01 |
| Normal-vs-N1 |
7.210600E-01 |
| N0-vs-N1 |
2.235000E-01 |
|
|
